← FDA Drug Approvals (Drugs@FDA)

ATEBRIOZ

NDA · New Drug Application · Sponsor: INCYTE CORP · Approved 2026-09-25

Drug application

FDA Application #

NDA221198

Application type

New Drug Application

Brand name

ATEBRIOZ

Generic name

Zilurgisertib

Active ingredients

ZILURGISERTIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

INCYTE CORP

First approval

2026-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown